Titre : Autoanticorps

Autoanticorps : Questions médicales fréquentes

Termes MeSH sélectionnés :

Lab-On-A-Chip Devices
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Autoanticorps : Questions médicales les plus fréquentes", "headline": "Autoanticorps : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Autoanticorps : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-22", "dateModified": "2025-02-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Autoanticorps" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Anticorps", "url": "https://questionsmedicales.fr/mesh/D000906", "about": { "@type": "MedicalCondition", "name": "Anticorps", "code": { "@type": "MedicalCode", "code": "D000906", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps anti-protéines citrullinées", "alternateName": "Anti-Citrullinated Protein Antibodies", "url": "https://questionsmedicales.fr/mesh/D000075422", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-protéines citrullinées", "code": { "@type": "MedicalCode", "code": "D000075422", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.095" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antinucléaires", "alternateName": "Antibodies, Antinuclear", "url": "https://questionsmedicales.fr/mesh/D000974", "about": { "@type": "MedicalCondition", "name": "Anticorps antinucléaires", "code": { "@type": "MedicalCode", "code": "D000974", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.204" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antiphospholipides", "alternateName": "Antibodies, Antiphospholipid", "url": "https://questionsmedicales.fr/mesh/D017152", "about": { "@type": "MedicalCondition", "name": "Anticorps antiphospholipides", "code": { "@type": "MedicalCode", "code": "D017152", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.210" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps anticardiolipines", "alternateName": "Antibodies, Anticardiolipin", "url": "https://questionsmedicales.fr/mesh/D017153", "about": { "@type": "MedicalCondition", "name": "Anticorps anticardiolipines", "code": { "@type": "MedicalCode", "code": "D017153", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.210.100" } } } ] }, { "@type": "MedicalWebPage", "name": "Facteur néphritique C3", "alternateName": "Complement C3 Nephritic Factor", "url": "https://questionsmedicales.fr/mesh/D003178", "about": { "@type": "MedicalCondition", "name": "Facteur néphritique C3", "code": { "@type": "MedicalCode", "code": "D003178", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.300" } } }, { "@type": "MedicalWebPage", "name": "Immunoconglutinines", "alternateName": "Immunoconglutinins", "url": "https://questionsmedicales.fr/mesh/D037561", "about": { "@type": "MedicalCondition", "name": "Immunoconglutinines", "code": { "@type": "MedicalCode", "code": "D037561", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.390" } } }, { "@type": "MedicalWebPage", "name": "Immunoglobulines thyréostimulantes", "alternateName": "Immunoglobulins, Thyroid-Stimulating", "url": "https://questionsmedicales.fr/mesh/D018828", "about": { "@type": "MedicalCondition", "name": "Immunoglobulines thyréostimulantes", "code": { "@type": "MedicalCode", "code": "D018828", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.480" } } }, { "@type": "MedicalWebPage", "name": "Facteur rhumatoïde", "alternateName": "Rheumatoid Factor", "url": "https://questionsmedicales.fr/mesh/D012217", "about": { "@type": "MedicalCondition", "name": "Facteur rhumatoïde", "code": { "@type": "MedicalCode", "code": "D012217", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.732" } } } ], "about": { "@type": "MedicalCondition", "name": "Autoanticorps", "alternateName": "Autoantibodies", "code": { "@type": "MedicalCode", "code": "D001323", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Iago Pinal-Fernandez", "url": "https://questionsmedicales.fr/author/Iago%20Pinal-Fernandez", "affiliation": { "@type": "Organization", "name": "Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA andrew.mammen@nih.gov iago.pinalfernandez@nih.gov." } }, { "@type": "Person", "name": "Katherine Pak", "url": "https://questionsmedicales.fr/author/Katherine%20Pak", "affiliation": { "@type": "Organization", "name": "Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA." } }, { "@type": "Person", "name": "Sarah L Tansley", "url": "https://questionsmedicales.fr/author/Sarah%20L%20Tansley", "affiliation": { "@type": "Organization", "name": "Department of Pharmacy and pharmacology, University of Bath, Bath, UK." } }, { "@type": "Person", "name": "Gunnar Houen", "url": "https://questionsmedicales.fr/author/Gunnar%20Houen", "affiliation": { "@type": "Organization", "name": "Department of Autoimmunology, Statens Serum Institut, Copenhagen, Denmark. gh@ssi.dk." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Repeated Filling of Elastomeric Pumps for Home-Based Subcutaneous Infusions: A Cost Analysis of 240 Devices.", "datePublished": "2024-03-20", "url": "https://questionsmedicales.fr/article/38509692", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/10499091241239929" } }, { "@type": "ScholarlyArticle", "name": "Machine learning-powered compact modeling of stochastic electronic devices using mixture density networks.", "datePublished": "2024-03-16", "url": "https://questionsmedicales.fr/article/38493250", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-56779-8" } }, { "@type": "ScholarlyArticle", "name": "Reconfigurable Micro/Nano-Optical Devices Based on Phase Transitions: From Materials, Mechanisms to Applications.", "datePublished": "2024-03-15", "url": "https://questionsmedicales.fr/article/38489745", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/advs.202306344" } }, { "@type": "ScholarlyArticle", "name": "Impella 5.5 Bridge to Heart Transplant: An Institutional Series and a Closer Look at Device Removal Technique.", "datePublished": "2024-03-14", "url": "https://questionsmedicales.fr/article/38502147", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MAT.0000000000002193" } }, { "@type": "ScholarlyArticle", "name": "Afterglow Nanoprobe-Enabled Quantitative Lateral Flow Immunoassay by a Palm-Size Device for Household Healthcare.", "datePublished": "2024-03-10", "url": "https://questionsmedicales.fr/article/38462674", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.analchem.3c05448" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Globulines", "item": "https://questionsmedicales.fr/mesh/D005916" }, { "@type": "ListItem", "position": 5, "name": "Sérum-globulines", "item": "https://questionsmedicales.fr/mesh/D012712" }, { "@type": "ListItem", "position": 6, "name": "Immunoglobulines", "item": "https://questionsmedicales.fr/mesh/D007136" }, { "@type": "ListItem", "position": 7, "name": "Anticorps", "item": "https://questionsmedicales.fr/mesh/D000906" }, { "@type": "ListItem", "position": 8, "name": "Autoanticorps", "item": "https://questionsmedicales.fr/mesh/D001323" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Autoanticorps - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Autoanticorps", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Autoanticorps", "description": "Comment détecte-t-on les autoanticorps ?\nQuels tests sont utilisés pour les autoanticorps ?\nLes autoanticorps sont-ils toujours présents dans les maladies auto-immunes ?\nPeut-on avoir des autoanticorps sans symptômes ?\nQuel rôle jouent les autoanticorps dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D001323?mesh_terms=Lab-On-A-Chip+Devices&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Autoanticorps", "description": "Quels symptômes sont associés aux autoanticorps ?\nLes autoanticorps causent-ils des douleurs articulaires ?\nPeut-on avoir des symptômes neurologiques avec des autoanticorps ?\nLes éruptions cutanées sont-elles liées aux autoanticorps ?\nLes autoanticorps peuvent-ils affecter les organes internes ?", "url": "https://questionsmedicales.fr/mesh/D001323?mesh_terms=Lab-On-A-Chip+Devices&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Autoanticorps", "description": "Peut-on prévenir la production d'autoanticorps ?\nLes vaccinations influencent-elles les autoanticorps ?\nLe stress peut-il augmenter les autoanticorps ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLes examens médicaux réguliers aident-ils à la prévention ?", "url": "https://questionsmedicales.fr/mesh/D001323?mesh_terms=Lab-On-A-Chip+Devices&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Autoanticorps", "description": "Comment traite-t-on les maladies liées aux autoanticorps ?\nLes traitements sont-ils les mêmes pour tous les autoanticorps ?\nLes thérapies biologiques sont-elles efficaces contre les autoanticorps ?\nPeut-on guérir des maladies causées par des autoanticorps ?\nLes changements de mode de vie aident-ils à gérer les autoanticorps ?", "url": "https://questionsmedicales.fr/mesh/D001323?mesh_terms=Lab-On-A-Chip+Devices&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Autoanticorps", "description": "Quelles complications peuvent survenir avec des autoanticorps ?\nLes autoanticorps peuvent-ils causer des maladies cardiovasculaires ?\nLes complications sont-elles réversibles ?\nLes infections sont-elles plus fréquentes avec des autoanticorps ?\nLes complications neurologiques sont-elles possibles ?", "url": "https://questionsmedicales.fr/mesh/D001323?mesh_terms=Lab-On-A-Chip+Devices&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Autoanticorps", "description": "Quels sont les facteurs de risque pour les autoanticorps ?\nL'âge influence-t-il la production d'autoanticorps ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLe tabagisme est-il un facteur de risque ?\nLes déséquilibres hormonaux affectent-ils les autoanticorps ?", "url": "https://questionsmedicales.fr/mesh/D001323?mesh_terms=Lab-On-A-Chip+Devices&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on les autoanticorps ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les autoanticorps sont détectés par des tests sanguins spécifiques, comme l'ELISA." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour les autoanticorps ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests courants incluent le dosage des anticorps antinucléaires (ANA) et des anticorps spécifiques." } }, { "@type": "Question", "name": "Les autoanticorps sont-ils toujours présents dans les maladies auto-immunes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, leur présence peut varier selon la maladie et le stade de la maladie." } }, { "@type": "Question", "name": "Peut-on avoir des autoanticorps sans symptômes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent avoir des autoanticorps sans présenter de symptômes cliniques." } }, { "@type": "Question", "name": "Quel rôle jouent les autoanticorps dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils aident à confirmer le diagnostic de maladies auto-immunes et à évaluer leur activité." } }, { "@type": "Question", "name": "Quels symptômes sont associés aux autoanticorps ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient, mais peuvent inclure fatigue, douleurs articulaires et éruptions cutanées." } }, { "@type": "Question", "name": "Les autoanticorps causent-ils des douleurs articulaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent provoquer des douleurs articulaires dans des maladies comme la polyarthrite rhumatoïde." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes neurologiques avec des autoanticorps ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains autoanticorps sont associés à des troubles neurologiques comme la sclérose en plaques." } }, { "@type": "Question", "name": "Les éruptions cutanées sont-elles liées aux autoanticorps ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des éruptions cutanées peuvent survenir dans des maladies comme le lupus érythémateux systémique." } }, { "@type": "Question", "name": "Les autoanticorps peuvent-ils affecter les organes internes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent endommager des organes comme les reins, le cœur ou les poumons dans certaines maladies." } }, { "@type": "Question", "name": "Peut-on prévenir la production d'autoanticorps ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode garantie, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles les autoanticorps ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent déclencher des autoanticorps, mais les bénéfices l'emportent souvent." } }, { "@type": "Question", "name": "Le stress peut-il augmenter les autoanticorps ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut exacerber les maladies auto-immunes et augmenter les autoanticorps." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en antioxydants et en oméga-3 peut aider à réduire l'inflammation." } }, { "@type": "Question", "name": "Les examens médicaux réguliers aident-ils à la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers peuvent aider à détecter précocement les maladies auto-immunes." } }, { "@type": "Question", "name": "Comment traite-t-on les maladies liées aux autoanticorps ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut des immunosuppresseurs, des anti-inflammatoires et des corticostéroïdes." } }, { "@type": "Question", "name": "Les traitements sont-ils les mêmes pour tous les autoanticorps ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, le traitement dépend du type de maladie auto-immune et des autoanticorps présents." } }, { "@type": "Question", "name": "Les thérapies biologiques sont-elles efficaces contre les autoanticorps ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines thérapies biologiques ciblent spécifiquement les mécanismes des maladies auto-immunes." } }, { "@type": "Question", "name": "Peut-on guérir des maladies causées par des autoanticorps ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de guérison, mais les traitements peuvent contrôler les symptômes et la progression." } }, { "@type": "Question", "name": "Les changements de mode de vie aident-ils à gérer les autoanticorps ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée, l'exercice et la gestion du stress peuvent aider à la gestion." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des autoanticorps ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des dommages aux organes, des infections et des troubles auto-immuns." } }, { "@type": "Question", "name": "Les autoanticorps peuvent-ils causer des maladies cardiovasculaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains autoanticorps sont associés à un risque accru de maladies cardiovasculaires." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent causer des dommages permanents." } }, { "@type": "Question", "name": "Les infections sont-elles plus fréquentes avec des autoanticorps ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients avec des maladies auto-immunes ont un risque accru d'infections." } }, { "@type": "Question", "name": "Les complications neurologiques sont-elles possibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications neurologiques peuvent survenir, comme des troubles cognitifs ou des crises." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les autoanticorps ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, le sexe féminin et certaines infections." } }, { "@type": "Question", "name": "L'âge influence-t-il la production d'autoanticorps ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la production d'autoanticorps augmente souvent avec l'âge, surtout chez les femmes." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines ou à des infections peut déclencher la production d'autoanticorps." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est associé à un risque accru de maladies auto-immunes et d'autoanticorps." } }, { "@type": "Question", "name": "Les déséquilibres hormonaux affectent-ils les autoanticorps ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les déséquilibres hormonaux, notamment chez les femmes, peuvent influencer la production d'autoanticorps." } } ] } ] }

Sources (10000 au total)

Repeated Filling of Elastomeric Pumps for Home-Based Subcutaneous Infusions: A Cost Analysis of 240 Devices.

The use of continuous subcutaneous infusion of drugs using the repeated filling of elastomeric infuser pumps (EIP) has gained clinical recognition for palliative care at home. However, to date, there ... We conducted an analysis of the cost associated to the repeated filling of 240 EIP (1-day, n = 136; 2-day, n = 102; 7-day, n = 2) (110 patients).... The refilling procedure led to a reduction in the utilization of 409 devices, resulting in savings of €4.031. EIP refilling did not result in a decrease in the number of home visits, the duration of e... Refilling EIPs reduces costs by reducing the number of devices purchased. No additional cost savings were noted in nursing time, number of home visits and duration, and expenses with transportation. F...

A new medical device applied in a case of acute fecal impaction with overflow diarrhea: a case report.

Fecal impaction is a digestive system disease, that is most common in the elderly population and becomes more prevalent with increasing age. Manual removal can successfully remove the impaction in 80%... A 78-year-old Han Chinese man living in a nursing home was diagnosed with fecal impaction; his initial symptom was overflow diarrhea, which is a rare occurrence with regard to fecal impaction. Neverth... Early identification of fecal impaction with atypical symptoms is crucial to provide proper emergency management. A safe and noninvasive treatment method, especially for elderly patients with fecal im...

Pre- and Post-Implant Endoscopy in Left Ventricular Assist Device Recipients: A Single-Center Experience.

Gastrointestinal bleeding (GIB) is common in left ventricular assist devices (LVADs) patients, but the optimal screening approach before LVAD implantation is still unclear. The aim of the study was to... A retrospective review was conducted among all patients who underwent LVAD implantation at Saint Luke's Hospital, between 2010 and 2020. The data were reviewed to determine the yield and safety of end... A total of 167 LVAD patients met the inclusion criteria, and 23 underwent pre-implantation endoscopic evaluation. Angiodysplasia had a significantly higher odds ratio (OR) of 9.41 (95% confidence inte... According to our results, we recommend against routine pre-LVAD endoscopic screening. Instead, we suggest an individualized approach, where decisions are made on a case-by-case basis....

Use of the pRESET LITE thrombectomy device in combined approach for medium vessel occlusions: A multicenter evaluation.

Our purpose was to assess the efficacy and safety of the pRESET LITE stent retriever (Phenox, Bochum, Germany), designed for medium vessel occlusion (MeVO) in acute ischemic stroke (AIS) patients with... We performed a retrospective analysis of the MAD MT Consortium, an integration of prospectively maintained databases at 37 academic institutions in Europe, North America, and Asia, of AIS patients who... Between September 2016 and December 2021, 227 patients were included (50% female, median age 78 [65-84] years), of whom 161 (71%) suffered proximal MeVO and 66 (29%) distal MeVO. Using a combined appr... Mechanical thrombectomy using the pRESET LITE in a combined approach with an aspiration catheter appears effective for primary medium vessel occlusions across several centers and physicians....